Real-world evidence study shows the significant impact of hyperkalaemia on cardiorenal patient outcomes pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
This feature articles commemorates the 10-year anniversary of the FDA's first approval of an SGLT2 inhibitor on March 29, 2013 and provides a snapshot at the class's ascent into the treatment algorithms and guidelines for type 2 diabetes, heart failure, and chronic kidney disease.
Pharmacist prescriber Penny Clark says the need to change cilazapril may be an opportunity to optimise drug therapy, especially if there are any concerns regarding effectiveness, adverse drug effects or the ‘triple whammy’